PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 29.894
EU - Europa 14.514
AS - Asia 3.055
SA - Sud America 121
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 47.643
Nazione #
US - Stati Uniti d'America 29.594
DE - Germania 5.448
DK - Danimarca 2.797
IT - Italia 2.087
CN - Cina 1.151
SE - Svezia 831
SG - Singapore 743
IE - Irlanda 622
RU - Federazione Russa 543
UA - Ucraina 484
HK - Hong Kong 459
GB - Regno Unito 364
PL - Polonia 338
FR - Francia 298
CA - Canada 283
VN - Vietnam 278
AT - Austria 215
FI - Finlandia 162
ID - Indonesia 108
IN - India 106
BR - Brasile 100
NL - Olanda 92
BE - Belgio 84
TR - Turchia 68
ES - Italia 43
JP - Giappone 42
RO - Romania 30
IR - Iran 26
CH - Svizzera 16
PK - Pakistan 14
EU - Europa 12
LT - Lituania 11
MX - Messico 11
AU - Australia 10
GR - Grecia 10
IL - Israele 10
TW - Taiwan 10
CZ - Repubblica Ceca 8
CL - Cile 7
EG - Egitto 7
AR - Argentina 6
BG - Bulgaria 6
MA - Marocco 6
MY - Malesia 6
PH - Filippine 6
KR - Corea 5
MU - Mauritius 5
NO - Norvegia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
EC - Ecuador 3
SC - Seychelles 3
UZ - Uzbekistan 3
A1 - Anonimo 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
LV - Lettonia 2
TH - Thailandia 2
TN - Tunisia 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
GL - Groenlandia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 47.643
Città #
Ann Arbor 19.992
Frankfurt am Main 5.121
Woodbridge 1.150
Wilmington 1.090
Chandler 942
Fairfield 884
Milan 656
Dublin 597
Houston 589
Singapore 581
Ashburn 575
Jacksonville 503
Hong Kong 452
Seattle 358
Kraków 329
Dearborn 310
Santa Clara 281
Cambridge 268
Rome 245
Princeton 232
Dong Ket 220
Vienna 201
Nanjing 183
New York 144
Shanghai 140
Boardman 139
Altamura 131
Guangzhou 114
Beijing 112
Lawrence 107
Jakarta 104
Toronto 90
Brussels 82
Council Bluffs 82
Lachine 80
San Diego 78
Helsinki 59
Florence 56
Ottawa 49
Fremont 44
Falls Church 42
Jinan 41
Montréal 39
Tianjin 39
Hebei 38
Andover 36
Nanchang 36
Shenyang 36
Hangzhou 31
Changsha 30
Huizen 29
Norwalk 28
Jiaxing 25
Mountain View 25
London 24
Los Angeles 24
Monza 22
Nuremberg 20
Zhengzhou 20
Kunming 19
Munich 19
Turin 19
Chicago 18
Duncan 17
Edmonton 16
Redmond 16
Paris 15
São Paulo 15
Tokyo 15
Grafing 14
University Park 14
Cinisello Balsamo 13
Como 13
Kiev 13
Ningbo 13
Taiyuan 13
Washington 13
Brescia 12
Haikou 12
Kocaeli 12
Leawood 12
Pune 12
Romola 12
Amsterdam 11
Berlin 11
Napoli 11
Auburn Hills 10
Hefei 10
Lappeenranta 10
Monmouth Junction 10
Seregno 10
Taizhou 10
Brunswick 9
Carate Brianza 9
Donostia / San Sebastian 9
Naples 9
Padova 9
Phoenix 9
Saint Petersburg 9
Trieste 9
Totale 38.467
Nome #
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 686
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 655
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 650
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 625
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 613
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 572
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 570
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 555
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 548
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 542
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 535
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 527
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 526
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 517
Binding properties and biological characterization of new sugar-derived Ras ligands 516
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 504
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 502
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 502
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 502
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 497
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 484
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 483
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 482
How do viruses interfere with Toll-like receptor 4? 478
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 477
Synthesis and biological evaluation of novel lipid A antagonists 477
Uniform Lipopolysaccharide (LPS)-Loaded Magnetic Nanoparticles for the Investigation of LPS–TLR4 Signaling 473
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 473
Exploring the LPS/TLR4 signal pathway with small molecules 471
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 464
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 463
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 462
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 462
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 462
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 460
A new isoluminol reagent for chemiluminescence labeling of proteins 459
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 457
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 454
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 443
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 443
Clustered carbohydrates in synthetic vaccines 441
Sugar-derived Ras inhibitors: group epitope mapping by NMR spectroscopy and biological evaluation 439
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 436
Design and characterisation of a new class of inhibitors of Ras activation 435
Multivalent glycoconjugates as anti-pathogenic agents 435
Modulation of LPS signaling through TLR4 agonists and antagonists 434
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 433
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 431
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 430
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 430
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 426
Carbohydrate-based bioactive compounds for medicinal chemistry applications 425
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 419
Optimizing operating conditions and electrochemical characterization of glucose–gluconate alkaline fuel cells 418
Rigid polycycles and peptidomimetics from carbohydrate synthons 417
Editorial 417
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 413
Chemistry of lipid a: At the heart of innate immunity 405
Chemoselective neoglycosylation 404
Looking forward: A glance into the future of organic chemistry 401
Glycoconjugates in cancer therapy 398
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 398
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 391
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 390
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 389
Studies on the mechanism of action of a new class of inhibitors of Ras activation 389
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 388
Polycyclic Scaffolds from Fructose 387
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 387
Carbohydrate Scaffolds for the Production of Bioactive Compounds 385
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 385
Chemoselective Ligation in Glycochemistry 384
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 382
Discrimination Properties of Tetraamidic Branched Selectors 382
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 382
The EuroSciCon's 2015 Innate Immunity Summit 381
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 377
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 377
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 375
Synthesis of imino-C-disaccharides related to sucrose 368
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 366
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 366
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 366
A new procedure for the synthesis of C-glycosides of nojirimycin 362
Bicyclic carbohydrate-derived scaffolds for combinatorial libraries 361
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 358
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 355
Conversion of lactose into mimics of N-acetyllactosamine 353
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 350
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 348
Synthesis and conformational analysis of novel N(OCH3) disaccharide analogues 347
Chemo- and stereoselective glycosylation of hydroxylamino derivatives: A versatile approach to glycoconjugates 347
Glycidic scaffolds in Peptidomimetic synthesis 346
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 345
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 345
On the regioselectivity of the protease subtilisin towards the acylation of enantiomeric pairs of benzyl and naphthyl glycopyranosides. Part 2 342
Conformational features of a synthetic model of the first extracellular loop of the angiotensin II AT1A receptor 336
Enzyme Mediated Acylation of Benzyl Beta D and L-Glucopiranoside: A Remarkable Example of Enantiomeric Recognition by Regioselective Transformation 336
Novel Tn antigen containing neoglycopeptides: synthesis and evaluation as antitumour vaccines 330
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 330
Totale 43.644
Categoria #
all - tutte 109.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.366 0 0 0 0 0 0 0 610 910 989 1.010 847
2020/202112.003 1.070 730 891 1.144 942 978 1.033 1.187 911 1.052 816 1.249
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20253.011 324 548 455 326 461 300 334 263 0 0 0 0
Totale 48.997